BioCentury | Nov 15, 2010
Finance

RX+DX gambit

...payments from collaborations. Investors include Perseus-Soros (19.2% pre-IPO stake); Apposite Capital (13.3%); Forward Ventures (11.9%); Roche Finance...
BioCentury | Mar 13, 2000
Finance

Changing of the guard

...in Iceland to create and operate a national medical and genetic database(see BioCentury, Jan. 31). Roche Finance...
BioCentury | Jun 30, 1997
Finance

A week to forget

...valuation. HealthCare Investment Corp. will own 23 percent of the company post-deal, while Warner-Lambert and Roche Finance...
Items per page:
1 - 3 of 3
BioCentury | Nov 15, 2010
Finance

RX+DX gambit

...payments from collaborations. Investors include Perseus-Soros (19.2% pre-IPO stake); Apposite Capital (13.3%); Forward Ventures (11.9%); Roche Finance...
BioCentury | Mar 13, 2000
Finance

Changing of the guard

...in Iceland to create and operate a national medical and genetic database(see BioCentury, Jan. 31). Roche Finance...
BioCentury | Jun 30, 1997
Finance

A week to forget

...valuation. HealthCare Investment Corp. will own 23 percent of the company post-deal, while Warner-Lambert and Roche Finance...
Items per page:
1 - 3 of 3